MA52738A - Méthodes de traitement de l'arthrite psoriasique - Google Patents
Méthodes de traitement de l'arthrite psoriasiqueInfo
- Publication number
- MA52738A MA52738A MA052738A MA52738A MA52738A MA 52738 A MA52738 A MA 52738A MA 052738 A MA052738 A MA 052738A MA 52738 A MA52738 A MA 52738A MA 52738 A MA52738 A MA 52738A
- Authority
- MA
- Morocco
- Prior art keywords
- treatment methods
- arthritis treatment
- psoriasic arthritis
- psoriasic
- methods
- Prior art date
Links
- 206010003246 arthritis Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1808575.3A GB201808575D0 (en) | 2018-05-24 | 2018-05-24 | Methods for the treatment of psoriatic arthrits |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA52738A true MA52738A (fr) | 2021-04-14 |
Family
ID=62812304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA052738A MA52738A (fr) | 2018-05-24 | 2019-05-23 | Méthodes de traitement de l'arthrite psoriasique |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20210299135A1 (fr) |
| EP (1) | EP3801548A1 (fr) |
| JP (2) | JP2021524472A (fr) |
| KR (1) | KR20210013168A (fr) |
| CN (1) | CN112203660A (fr) |
| AU (1) | AU2019273664A1 (fr) |
| CA (1) | CA3101386A1 (fr) |
| GB (1) | GB201808575D0 (fr) |
| MA (1) | MA52738A (fr) |
| WO (1) | WO2019224283A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4178616A1 (fr) * | 2020-07-13 | 2023-05-17 | Janssen Biotech, Inc. | Méthode sûre et efficace de traitement de l'arthrite psoriasique au moyen d'un anticorps spécifique anti-il23 |
| EP4287299A1 (fr) | 2021-01-29 | 2023-12-06 | LG Chem, Ltd. | Électrode |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI462920B (zh) * | 2009-06-26 | 2014-12-01 | 葛萊伯格有限公司 | 用於治療退化性及發炎疾病之新穎化合物 |
| EA029084B1 (ru) * | 2012-06-22 | 2018-02-28 | Галапагос Нв | Аминотриазолопиридин для применения в лечении воспаления и его фармацевтические композиции |
| GB201402071D0 (en) | 2014-02-07 | 2014-03-26 | Galapagos Nv | Novel salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
| GB201402070D0 (en) | 2014-02-07 | 2014-03-26 | Galapagos Nv | Pharmaceutical compositions for the treatment of inflammatory disorders |
| SG11201708181RA (en) * | 2015-04-13 | 2017-11-29 | Galapagos Nv | Methods for the treatment of inflammatory disorders |
| US20170173034A1 (en) * | 2015-12-17 | 2017-06-22 | Gilead Sciences, Inc. | Combination of a jak inhibitor and a syk inhibitor for treating cancers and inflammatory disorders |
| JOP20180018A1 (ar) * | 2017-03-14 | 2019-01-30 | Gilead Sciences Inc | تركيبات صيدلية تتضمن مثبط jak |
-
2018
- 2018-05-24 GB GBGB1808575.3A patent/GB201808575D0/en not_active Ceased
-
2019
- 2019-05-23 CA CA3101386A patent/CA3101386A1/fr active Pending
- 2019-05-23 KR KR1020207036941A patent/KR20210013168A/ko unknown
- 2019-05-23 CN CN201980034599.1A patent/CN112203660A/zh active Pending
- 2019-05-23 WO PCT/EP2019/063283 patent/WO2019224283A1/fr unknown
- 2019-05-23 EP EP19726950.9A patent/EP3801548A1/fr active Pending
- 2019-05-23 MA MA052738A patent/MA52738A/fr unknown
- 2019-05-23 AU AU2019273664A patent/AU2019273664A1/en active Pending
- 2019-05-23 US US17/057,946 patent/US20210299135A1/en active Pending
- 2019-05-23 JP JP2020565417A patent/JP2021524472A/ja active Pending
-
2024
- 2024-02-16 JP JP2024021644A patent/JP2024069223A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| GB201808575D0 (en) | 2018-07-11 |
| WO2019224283A1 (fr) | 2019-11-28 |
| EP3801548A1 (fr) | 2021-04-14 |
| KR20210013168A (ko) | 2021-02-03 |
| CN112203660A (zh) | 2021-01-08 |
| AU2019273664A1 (en) | 2021-01-21 |
| US20210299135A1 (en) | 2021-09-30 |
| JP2021524472A (ja) | 2021-09-13 |
| JP2024069223A (ja) | 2024-05-21 |
| CA3101386A1 (fr) | 2019-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA45192A (fr) | Traitement d'association | |
| MA44083A (fr) | Composés de biarylmonobactame pour le traitement d'infections bactériennes | |
| MA45539A (fr) | Dihydropyranopyrimidines pour le traitement d'infections virales | |
| MA46954A (fr) | Méthodes de traitement d'états inflammatoires | |
| MA52371A (fr) | Méthodes de traitement d'infections dues aux coronaviridae | |
| MA45036A (fr) | Polynucléotides codant pour la citrine pour le traitement de la citrullinémie de type 2 | |
| MA40867A (fr) | Méthodes pour le traitement d'infections virales à filoviridae | |
| MA47719A (fr) | Esketamine pour le traitement de la dépression | |
| MA53329A (fr) | Méthodes de traitement de l'épilepsie | |
| MA43811A (fr) | Composés d'arylmonobactame bicycliques et leurs méthodes d'utilisation pour le traitement des infections bactériennes | |
| MA47504A (fr) | Composés et méthodes de traitement de l'angiocholite biliaire primitive | |
| MA47820A (fr) | Traitement de la glycogénose de type iii | |
| MA42999A (fr) | Polythérapie pour le traitement de malignités | |
| MA46353A (fr) | Méthodes de traitement de l'infertilité féminine | |
| MA52216A (fr) | Méthodes de traitement de la colite ulcéreuse | |
| MA51525A (fr) | Traitement de minéraux | |
| MA49576A (fr) | Compositions et méthodes pour le traitement d'infections fongiques | |
| MA51738A (fr) | Composés pour le traitement de la douleur | |
| MA45552A (fr) | Compositions destinées au traitement de l'amylose | |
| MA51678A (fr) | Méthodes de traitement de l'amyotrophie musculaire | |
| MA54860A (fr) | Méthodes de traitement du myélome multiple | |
| MA45973A (fr) | Combinaisons d'inhibiteurs de btk pour le traitement du myélome multiple | |
| MA47437A (fr) | Procédés de traitement d'infections fongiques | |
| MA53924A (fr) | Modulateurs de l'expression d'apol1 | |
| MA43825A (fr) | Schémas posologiques pour le traitement d'infections fongiques |